Carnitine or dimethyl sulfoxide, or both, for the treatment of anthracycline extravasation in rats

References

• Kassner E. Evaluation and treatment of chemotherapy extravasation injuries. J Pediatr Oncol Nurs 2000;17:135–48.
   PubMed Web of Science ®Google Scholar
• Goolsby TV, Lombardo FA. Extravasation of chemotherapeutic agents: prevention and treatment. Semin Oncol 2006;33:139–43.
   PubMed Web of Science ®Google Scholar
• Monstrey SJ, Mullick P, Narayanan K, Ramasastry SS. Hyperbaric oxygen therapy and free radical production: an experimental study in doxorubicin extravasation injuries. Ann Plast Surg 1997;38:163–8.
   PubMed Web of Science ®Google Scholar
• Aktaş S, Toklu AS, Olgaç V. Hyperbaric oxygen therapy in adriamycin extravasation: an experimental animal study. Ann Plast Surg 2000;45:167–71.
   PubMed Web of Science ®Google Scholar
• Askar I, Erbas MK, Gurlek A. Effects of heparin fractions on the preventing of skin necrosis resulting from adriamycin extravasation: an experimental study. Ann Plast Surg 2002;49:297–301.
   PubMed Web of Science ®Google Scholar
• Hajarizadeh H, Lebredo L, Barrie R, Woltering EA. Protective effect of doxorubicin in vitamin C or dimethyl sulfoxide against skin ulceration in the pig. Ann Surg Oncol 1994;1:411–14.
   PubMed Web of Science ®Google Scholar
• Disa JJ, Chang RR, Mucci SJ, Goldberg NH. Prevention of Adriamycin-induced full-thickness skin loss using hyaluronidase infiltration. Plast Reconstr Surg 1998;101:370–4.
   PubMed Web of Science ®Google Scholar
• Schwartsmann G, Sander EB, Vinholes J, et al. N-acetylcysteine protects skin lesion induced by local extravasation of doxorubicin in a rat model. Am J Pediatr Hematol Oncol 1992;14:280–1.
   PubMedGoogle Scholar
• Lucero MJ, Vigo J, Rabasco AM, et al. Protection by alpha-tocopherol against skin necrosis induced by doxorubicin hydrochloride. Pharmazie 1993;48:772–5.
   PubMed Web of Science ®Google Scholar
• Bertelli G, Gozza A, Forno GB, et al. Topical dimethysulfoxide fort the prevention of soft tissue injury after extravasation of vesicant cytotoxic drugs: prospective clinical study. J Clin Oncol 1995;13:2851–5.
   PubMed Web of Science ®Google Scholar
• Vargel I, Erdem A, Ertoy D, et al. Effects of growth factors on doxorubicin induced skin necrosis: documentation of histomorphological alterations and early treatment by GM-CSF and G-CSF. Ann Plast Surg 2002;4:646–53.
   Google Scholar
• Yılmaz M, Demirdover C, Mola F. Treatment options in extravasation injury: an experimental study in rats. Plast Reconstr Surg 2002;109:2418–23.
   PubMed Web of Science ®Google Scholar
• Langer SW, Thougaard AV, Sehested M, Jensen PB. Treatment of anthracycline extravasation in mice with dexrazoxane with or without DMSO and hydrocortisone. Cancer Chemother Pharmacol 2006;57:125–8.
   PubMed Web of Science ®Google Scholar
• Mouridsen HT, Langer SW, Buter J, et al. Treatment of anthracycline extravasation with savane: results from two prospective clinical multicentre studies. Ann Oncol 2006;18:546–50.
   PubMed Web of Science ®Google Scholar
• Schrijvers DL. Extravasation: a dreaded complication of chemotherapy. Ann Onc 2003;14:26–30.
   Web of Science ®Google Scholar
• Packer L, Valenza M, Serbinova E, et al. Free radical scavenging is involved in the protective effect of L-propionyl-carnitine against ischemia-reperfusion injury of the heart. Arch Biochem Biophys 1991;288:533–7.
   PubMed Web of Science ®Google Scholar
• St Germain B, Houlihan N, D'Amato S. Dimethyl sulfoxide therapy in the treatment of vesicant extravasation: two case presentations. J Intraven Nurs 1994;17:261–6.
   PubMedGoogle Scholar
• Lawrence HJ, Walsh D, Zapotowski KA, et al. Topical dimethylsulfoxide may prevent tissue damage from anthracycline extravasation. Cancer Chemother Pharmacol 1989;23:316–18.
   PubMed Web of Science ®Google Scholar
• Dorr RT, Alberts DS. Failure of DMSO and vitamin E to prevent doxorubicin skin ulceration in the mouse. Cancer Treat Rep 1983;67:499–501.
   PubMedGoogle Scholar
• Santos NC, Figueira-Coelho J, Martins-Silva J, Saldanha C. Multidisciplinary utilization of dimethyl sulfoxide: pharmacological, cellular, and molecular aspects. Biochem Pharmacol 2003;65:1035–41.
   PubMed Web of Science ®Google Scholar
• David NA. The pharmacology of dimethyl sulphoxide. Annu Rev Pharmacol 1972;12:353–74.
   PubMedGoogle Scholar